Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Perronne

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
International Journal of Antimicrobial Agents|May 23, 2016
High rates of off-label use in antibiotic prescriptions in a context of dramatic resistance increase: a prospective study in a tertiary hospitalBenjamin Davido, Frédérique Bouchand, Ruxandra Calin, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimenBernard Masquelier, Cecile Droz, Martin Dary, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2008
Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factorsFirouzé Bani-Sadr, Nathanael Lapidus, Pierre Bedossa, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 3, 2015
Four days a week or less on appropriate anti-HIV drug combinations provided long-term optimal maintenance in 94 patients: the ICCARRE projectJacques Leibowitch, Dominique Mathez, Pierre de Truchis, et al.
The Journal of Infection|January 1, 2014
Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral responseEvguenia Krastinova, Firouzé Bani-Sadr, Delphine Fromentin, et al.
AIDS (London, England)|June 6, 2008
Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patientsFirouzé Bani-Sadr, Patrick Miailhes, Eric Rosenthal, et al.
International Journal of Rheumatology|November 12, 2016
Impact of Anti-Inflammatory Drugs on Pyogenic Vertebral Osteomyelitis: A Prospective Cohort StudyAurélien Dinh, Maxime Jean, Frédérique Bouchand, et al.
Vaccine|February 10, 2016
Implementing efficient and sustainable collaboration between National Immunization Technical Advisory Groups: Report on the 3rd International Technical Meeting, Paris, France, 8-9 December 2014Christian Perronne, Alex Adjagba, Philippe Duclos, et al.
The Journal of Infectious Diseases|December 31, 2013
α-Hemolysin, not Panton-Valentine leukocidin, impacts rabbit mortality from severe sepsis with methicillin-resistant Staphylococcus aureus osteomyelitisAnne-Claude Crémieux, Azzam Saleh-Mghir, Claire Danel, et al.
Antiviral Therapy|November 21, 2007
The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practiceVirginie Villes, Bruno Spire, Charlotte Lewden, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
International Journal of Antimicrobial Agents|May 23, 2016
High rates of off-label use in antibiotic prescriptions in a context of dramatic resistance increase: a prospective study in a tertiary hospitalBenjamin Davido, Frédérique Bouchand, Ruxandra Calin, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimenBernard Masquelier, Cecile Droz, Martin Dary, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2008
Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factorsFirouzé Bani-Sadr, Nathanael Lapidus, Pierre Bedossa, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 3, 2015
Four days a week or less on appropriate anti-HIV drug combinations provided long-term optimal maintenance in 94 patients: the ICCARRE projectJacques Leibowitch, Dominique Mathez, Pierre de Truchis, et al.
The Journal of Infection|January 1, 2014
Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral responseEvguenia Krastinova, Firouzé Bani-Sadr, Delphine Fromentin, et al.
AIDS (London, England)|June 6, 2008
Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patientsFirouzé Bani-Sadr, Patrick Miailhes, Eric Rosenthal, et al.
International Journal of Rheumatology|November 12, 2016
Impact of Anti-Inflammatory Drugs on Pyogenic Vertebral Osteomyelitis: A Prospective Cohort StudyAurélien Dinh, Maxime Jean, Frédérique Bouchand, et al.
Vaccine|February 10, 2016
Implementing efficient and sustainable collaboration between National Immunization Technical Advisory Groups: Report on the 3rd International Technical Meeting, Paris, France, 8-9 December 2014Christian Perronne, Alex Adjagba, Philippe Duclos, et al.
The Journal of Infectious Diseases|December 31, 2013
α-Hemolysin, not Panton-Valentine leukocidin, impacts rabbit mortality from severe sepsis with methicillin-resistant Staphylococcus aureus osteomyelitisAnne-Claude Crémieux, Azzam Saleh-Mghir, Claire Danel, et al.
Antiviral Therapy|November 21, 2007
The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practiceVirginie Villes, Bruno Spire, Charlotte Lewden, et al.
Pageof 10